Works matching IS 02683369 AND DT 2011 AND VI 46 AND IP 2

Results: 28

Blood stream infection (BSI) and acute GVHD after hematopoietic SCT (HSCT) are associated.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 2, p. 300, doi. 10.1038/bmt.2010.112

By:

Poutsiaka, D. D.;
Munson, D.;
Price, L. L.;
Chan, G. W.;
Snydman, D. R.

Publication type:

Article

A randomized, double-blind, placebo-controlled trial of valacyclovir prophylaxis to prevent zoster recurrence from months 4 to 24 after BMT.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 2, p. 294, doi. 10.1038/bmt.2010.99

By:

Klein, A.;
Miller, K. B.;
Sprague, K.;
DesJardin, J. A.;
Snydman, D. R.

Publication type:

Article

The impact of smoking on outcomes among patients undergoing hematopoietic SCT for the treatment of acute leukemia.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 2, p. 285, doi. 10.1038/bmt.2010.113

By:

Ehlers, S. L.;
Gastineau, D. A.;
Patten, C. A.;
Decker, P. A.;
Rausch, S. M.;
Cerhan, J. R.;
Hogan, W. J.;
Ebbert, J. O.;
Porrata, L. F.

Publication type:

Article

Toxoplasmosis in allo-SCT patients: risk factors and outcomes at a transplantation center with a low incidence.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 2, p. 273, doi. 10.1038/bmt.2010.102

By:

Mulanovich, V. E.;
Ahmed, S. I.;
Öztürk, T.;
Khokhar, F. A.;
Kontoyiannis, D. P.;
de Lima, M.

Publication type:

Article

Voriconazole for both successful treatment of disseminated Trichosporon asahii infection and subsequent cord blood transplantation in an infant with acute myelogenous leukemia.

Published in:

2011

By:

Kudo, K.;
Terui, K.;
Sasaki, S.;
Kamio, T.;
Sato, T.;
Ito, E.

Publication type:

Letter

Bortezomib and donor lymphocyte infusion in multiple myeloma relapsed after allo-SCT does not result in durable remissions.

Published in:

2011

By:

Hoevenaren, I. A.;
Van Vulpen, L. F. D.;
Levenga, H.;
Minnema, M. C.;
Raymakers, R.

Publication type:

Correction Notice

A single-nucleotide polymorphism of the Fcγ receptor type IIIA gene in the recipient predicts transplant outcomes after HLA fully matched unrelated BMT for myeloid malignancies.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 2, p. 238, doi. 10.1038/bmt.2010.88

By:

Takami, A.;
Espinoza, J. L.;
Onizuka, M.;
Ishiyama, K.;
Kawase, T.;
Kanda, Y.;
Sao, H.;
Akiyama, H.;
Miyamura, K.;
Okamoto, S.;
Inoue, M.;
Ohtake, S.;
Fukuda, T.;
Morishima, Y.;
Kodera, Y.;
Nakao, S.

Publication type:

Article

Unrelated cord blood transplantation after myeloablative conditioning in adults with advanced myelodysplastic syndromes.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 2, p. 257, doi. 10.1038/bmt.2010.91

By:

Sato, A.;
Ooi, J.;
Takahashi, S.;
Tsukada, N.;
Kato, S.;
Kawakita, T.;
Yagyu, T.;
Nagamura, F.;
Iseki, T.;
Tojo, A.;
Asano, S.

Publication type:

Article

Co-infusion of ex vivo-expanded, parental MSCs prevents life-threatening acute GVHD, but does not reduce the risk of graft failure in pediatric patients undergoing allogeneic umbilical cord blood transplantation.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 2, p. 200, doi. 10.1038/bmt.2010.87

By:

Bernardo, M. E.;
Ball, L. M.;
Cometa, A. M.;
Roelofs, H.;
Zecca, M.;
Avanzini, M. A.;
Bertaina, A.;
Vinti, L.;
Lankester, A.;
Maccario, R.;
Ringden, O.;
Le Blanc, K.;
Egeler, R. M.;
Fibbe, W. E.;
Locatelli, F.

Publication type:

Article

Engraftment of unrelated cord blood after reduced-intensity conditioning regimen in children with refractory neuroblastoma: a feasibility trial.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 2, p. 232, doi. 10.1038/bmt.2010.107

By:

Jubert, C.;
Wall, D. A.;
Grimley, M.;
Champagne, M. A.;
Duval, M.

Publication type:

Article

Long-term outcomes in patients with high-risk myeloid malignancies following matched related donor hematopoietic cell transplantation with myeloablative conditioning of BU, etoposide and CY.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 2, p. 192, doi. 10.1038/bmt.2010.114

By:

Naik, S.;
Wong, R.;
Arai, S.;
Brown, J.;
Laport, G.;
Lowsky, R.;
Miklos, D.;
Shizuru, J.;
Blume, K.;
Negrin, R.;
Johnston, L.

Publication type:

Article

Autologous purified peripheral blood SCT in childhood low-risk relapsed ALL.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 2, p. 217, doi. 10.1038/bmt.2010.85

By:

Balduzzi, A.;
Bonanomi, S.;
Valsecchi, M. G.;
Gaipa, G.;
Perseghin, P.;
Songia, S.;
Maglia, O.;
Rossi, V.;
Motta, S.;
Di Maio, L.;
Dassi, M.;
Uderzo, C.;
Conter, V.;
Henze, G.;
Von Stackelberg, A.;
Rovelli, A.;
Biondi, A.;
Galimberti, S.

Publication type:

Article

Prophylactic oseltamivir treatment for prevention of donor-recipient influenza A H1N1 virus transmission does not compromise stem cell mobilization or engraftment.

Published in:

2011

By:

Rohn, A.;
Kessler, H. H.;
Valentin, T.;
Linkesch, W.;
Neumeister, P.

Publication type:

Letter

The EBMT activity survey 2008: impact of team size, team density and new trends.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 2, p. 174, doi. 10.1038/bmt.2010.69

By:

Gratwohl, A.;
Baldomero, H.;
Schwendener, A.;
Gratwohl, M.;
Apperley, J.;
Frauendorfer, K.;
Niederwieser, D.

Publication type:

Article

AMD3100 for urgent PBSC mobilization and allogeneic transplantation from a normal donor after failed marrow harvest.

Published in:

2011

By:

Leotta, S.;
Poidomani, M.;
Mauro, E.;
Spadaro, A.;
Marturano, E.;
Milone, G.

Publication type:

Letter

Evaluation of a surveillance strategy for early detection of adenovirus by PCR of peripheral blood in hematopoietic SCT recipients: incidence and outcome.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 2, p. 267, doi. 10.1038/bmt.2010.86

By:

Öhrmalm, L.;
Lindblom, A.;
Omar, H.;
Norbeck, O.;
Gustafson, I.;
Lewensohn-Fuchs, I.;
Johansson, J.-E.;
Brune, M.;
Ljungman, P.;
Broliden, K.

Publication type:

Article

Comparison of outcomes after auto-SCT for patients with relapsed diffuse large B-cell lymphoma according to previous therapy with rituximab.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 2, p. 262, doi. 10.1038/bmt.2010.95

By:

Smith, S. D.;
Bolwell, B. J.;
Rybicki, L. A.;
Kang, T.;
Dean, R.;
Advani, A.;
Thakkar, S.;
Sobecks, R.;
Kalaycio, M.;
Pohlman, B.;
Sweetenham, J. W.

Publication type:

Article

Pretransplant serum ferritin and C-reactive protein as predictive factors for early bacterial infection after allogeneic hematopoietic cell transplantation.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 2, p. 208, doi. 10.1038/bmt.2010.108

By:

Kanda, J.;
Mizumoto, C.;
Ichinohe, T.;
Kawabata, H.;
Saito, T.;
Yamashita, K.;
Kondo, T.;
Takakura, S.;
Ichiyama, S.;
Uchiyama, T.;
Ishikawa, T.

Publication type:

Article

Low risk of symptomatic venous thromboembolic events during growth factor administration for PBSC mobilization.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 2, p. 291, doi. 10.1038/bmt.2010.106

By:

Naina, H. V.;
Pruthi, R. K.;
Inwards, D. J.;
Dingli, D.;
Litzow, M. R.;
Ansell, S. M.;
William, H. J.;
Dispenzieri, A.;
Buadi, F. K.;
Elliott, M. A.;
Gastineau, D. A.;
Gertz, M. A.;
Hayman, S. R.;
Johnston, P. B.;
Lacy, M. Q.;
Micallef, I. N.;
Porrata, L. F.;
Kumar, S.

Publication type:

Article

Mesenchymal stromal cells as treatment for chronic GVHD.

Published in:

2011

By:

Ringden, O.;
Keating, A.

Publication type:

Editorial

The care of critically ill children after hematopoietic SCT: a North American survey.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 2, p. 227, doi. 10.1038/bmt.2010.89

By:

McArthur, J.;
Pettersen, G.;
Jouvet, P.;
Christensen, M.;
Tamburro, R.

Publication type:

Article

Addition of plerixafor to a chemotherapy plus G-CSF mobilization in hard-to-mobilize patients.

Published in:

2011

By:

Jantunen, E.;
Penttilä, K.;
Pyörälä, M.;
Mahlamäki, E.;
Kuittinen, T.;
Nousiainen, T.

Publication type:

Letter

Bone marrow mononuclear cells versus G-CSF-mobilized peripheral blood mononuclear cells for treatment of lower limb ASO: pooled analysis for long-term prognosis.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 2, p. 278, doi. 10.1038/bmt.2010.110

By:

Onodera, R.;
Teramukai, S.;
Tanaka, S.;
Kojima, S.;
Horie, T.;
Matoba, S.;
Murohara, T.;
Matsubara, H.;
Fukushima, M.

Publication type:

Article

Bortezomib and donor lymphocyte infusion in multiple myeloma relapsed after allo-SCT does not result in durable remissions.

Published in:

2011

By:

Hoevenaren, A.;
van Vulpen, L. F. D.;
Levenga, H.;
Minnema, M. C.;
Raymakers, R.

Publication type:

Letter

Antifungal prophylaxis in hematopoietic stem cell transplant recipients: the unfinished tale of imperfect success.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 2, p. 165, doi. 10.1038/bmt.2010.256

By:

Kontoyiannis, D. P.

Publication type:

Article

Parvovirus B19 as an etiological agent of acute pleuro-pericarditis.

Published in:

2011

By:

Castagna, L.;
Furst, S.;
El Cheikh, J.;
Faucher, C.;
Blaise, D.

Publication type:

Letter

Prognostic factors and outcome in relapsed multiple myeloma after nonmyeloablative allo-SCT: a single center experience.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 2, p. 244, doi. 10.1038/bmt.2010.101

By:

Minnema, M. C.;
van Dorp, S.;
van de Donk, N. W. C. J.;
Schouten, F.;
Kersten, M. J.;
Coenen, J. L. L. M.;
Schouten, H.;
Zweegman, S.;
Schaafsma, R.;
Lokhorst, H. M.

Publication type:

Article

Tandem autologous non-myeloablative allogeneic transplantation in patients with multiple myeloma relapsing after a first high dose therapy.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 2, p. 250, doi. 10.1038/bmt.2010.90

By:

Karlin, L.;
Arnulf, B.;
Chevret, S.;
Ades, L.;
Robin, M.;
De Latour, R. P.;
Malphettes, M.;
Kabbara, N.;
Asli, B.;
Rocha, V.;
Fermand, J. P.;
Socie, G.

Publication type:

Article